www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

SARS-CoV-2 peptide pools: PepMix

The PepMix™ range of peptide pools from JPT feature SARS-CoV-2 antigens and frequent mutations to enable in vitro stimulation of CD4+ and CD8+ T-cells for the measurement of T-cell response to specific SARS-CoV-2 antigens. These PepMixes contain overlapping peptide pools representing the Spike protein and corresponding receptor-binding domain (RBD) of the new B.1.1.7 SARS-CoV-2 variant, first reported in the UK.

Benefits of using the PepMix SARS-CoV-2 peptide pool
• Spike protein and RBD domain of B.1.1.7 variant represented
• Simultaneous CD4 and CD8 response detection in a single sample 
• Better or equivalent T-cell response stimulation compared to whole protein antigens
• Improved and easier T-cell response detection in stored blood and PBMCs compared to whole protein antigens
• Reliable quality control and quality assurance
• High batch-to-batch reproducibility
• Prolonged shelf life when stored freeze-dried
• Pooled and aliquoted according to ISO 9001:2008 and GCLP regulations

PepMix SARS-CoV-2 peptide pools applications
• SARS-CoV-2 clinical trial immune monitoring
• SARS-CoV-2 correlation of cellular and humoral immune responses
• SARS-CoV-2 evaluation of cross reactivities
• SARS-CoV-2 vaccine target identification
• SARS-CoV-2 blood and sero test development

PepMix SARS-CoV-2 peptide pools citations

Products

Note: product availability depends on country - see product detail page.

Details Cat number & supplier Size Price
PepMix™ SARS-CoV-2 (Spike Glycoprotein) PM-WCPV-S-1 · JPT Peptide Technologies
PM-WCPV-S-1
JPT Peptide Technologies
15 nmol (approx. 25 µg) per peptide £974.00
15 nmol (approx. 25 µg) per peptide
view
PepMix™ SARS-CoV-2 (NCAP) PM-WCPV-NCAP-1 · JPT Peptide Technologies
PM-WCPV-NCAP-1
JPT Peptide Technologies
15 nmol (approx. 25 µg) per peptide £483.00
15 nmol (approx. 25 µg) per peptide
view
PepMix™ SARS-CoV-2 (VME1) PM-WCPV-VME-2 · JPT Peptide Technologies
PM-WCPV-VME-2
JPT Peptide Technologies
15 nmol per peptide approx. 25 µg per peptide £649.00
15 nmol per peptide approx. 25 µg per peptide
view
PepMix™ SARS-CoV-2 (Spike Glycoprotein) PM-WCPV-S-2 · JPT Peptide Technologies
PM-WCPV-S-2
JPT Peptide Technologies
15 nmol per peptide approx. 25 µg per peptide £1363.00
15 nmol per peptide approx. 25 µg per peptide
view
PepMix™ SARS-CoV-2 (NCAP) PM-WCPV-NCAP-2 · JPT Peptide Technologies
PM-WCPV-NCAP-2
JPT Peptide Technologies
15 nmol per peptide approx. 25 µg per peptide £677.00
15 nmol per peptide approx. 25 µg per peptide
view
PepMix™ SARS-CoV-2 (S-RBD) PM-WCPV-S-RBD-2 · JPT Peptide Technologies
PM-WCPV-S-RBD-2
JPT Peptide Technologies
15 nmol (approx. 25 µg) per peptide £647.00
15 nmol (approx. 25 µg) per peptide
view
PepMix™ SARS-CoV-2 (S-RBD N501Y) PM-SARS2-RBDMUT01-1 · JPT Peptide Technologies
PM-SARS2-RBDMUT01-1
JPT Peptide Technologies
15 nmol (approx. 25 µg) per peptide £462.00
15 nmol (approx. 25 µg) per peptide
view
PepMix™ SARS-CoV-2 (S B.1.1.7 D614G) PM-SARS2-SMUT01-1 · JPT Peptide Technologies
PM-SARS2-SMUT01-1
JPT Peptide Technologies
15 nmol (approx. 25 µg) per peptide £971.00
15 nmol (approx. 25 µg) per peptide
view